Anmelden

Experimentica Ltd

3 ARTICLES PUBLISHED IN JoVE

image

Neuroscience

In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model
Symantas Ragauskas 1, Eva Kielczewski 2, Joseph Vance 2,3, Simon Kaja 1,4, Giedrius Kalesnykas 1
1Experimentica Ltd., 2Leica Microsystems, 3Spective LLC, 4Department of Ophthalmology, Stritch School of Medicine, Loyola University Chicago

Here, we present the usefulness of longitudinal in vivo imaging in the follow-up of morphological changes of laser-induced choroidal neovascularization in mice.

image

Cancer Research

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
Maria Vähätupa *1, Toini Pemmari *1, Ilkka Junttila 1,2, Marko Pesu 1,2, Tero A.H. Järvinen 1
1Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, 2Department of Clinical Microbiology, Fimlab Laboratories

Two-stage skin carcinogenesis is induced by two topically applied chemicals. A mutagen 7,12-dimethylbenz[a]anthracene) causes mutations in the epidermal cells and a continuous application of general growth stimulator 12-O-tetradecanoyl phorbol-13-acetate accelerates skin papilloma formation.

image

Medicine

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
Maria Vähätupa 1,2, Niina Jääskeläinen 2, Marc Cerrada-Gimenez 2, Rubina Thapa 2, Tero Järvinen 1, Giedrius Kalesnykas 2, Hannele Uusitalo-Järvinen 1,3
1Faculty of Medicine and Health Technology, Tampere University & Tampere University Hospital, 2Experimentica Ltd, 3Eye Centre, Tampere University Hospital

Oxygen-induced retinopathy (OIR) can be used to model ischemic retinal diseases such as retinopathy of prematurity and proliferative diabetic retinopathy and to serve as a model for proof-of-concept studies in evaluating antiangiogenic drugs for neovascular diseases. OIR induces robust and reproducible neovascularization in the retina that can be quantified.

JoVE Logo

Datenschutz

Nutzungsbedingungen

Richtlinien

Forschung

Lehre

ÜBER JoVE

Copyright © 2024 MyJoVE Corporation. Alle Rechte vorbehalten